Search results for "Hypothalamic Diseases"

showing 4 items of 4 documents

Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of th…

2016

Functional hypothalamic amenorrhea is a disorder characterized by cessation of menstrual cycles in the absence of organic disease. In most patients, it occurs in adult life after a stressful event and may be related to a condition of mild chronic energy deprivation. The endocrine pattern is characterized by low estrogen levels with an absent response to a progestogen challenge test and low-normal gonadotropin levels. A few studies have shown that some of these women may have some features of polycystic ovary syndrome; these features include an increased androgen response to gonadotropins, increased anti-Mullerian hormone levels, and altered ovarian morphology or increased ovarian size. Thes…

AdultAnti-Mullerian Hormoneendocrine systemmedicine.medical_specialtyendocrine system diseases030209 endocrinology & metabolismOvaryOrganic diseaseHypothalamic disease03 medical and health sciencesFollicle-stimulating hormoneYoung Adult0302 clinical medicineInternal medicinemedicineHumansTestosteroneAmenorrheaRetrospective Studies030219 obstetrics & reproductive medicinebiologybusiness.industryOvaryAndrostenedioneObstetrics and GynecologyAnti-Müllerian hormoneDehydroepiandrosteroneOrgan SizeLuteinizing Hormonemedicine.diseasePolycystic ovaryEndocrinologymedicine.anatomical_structureCase-Control Studiesbiology.proteinAmenorrheaFemalemedicine.symptomFollicle Stimulating HormoneLuteinizing hormonebusinessHypothalamic DiseasesPolycystic Ovary SyndromeAmerican journal of obstetrics and gynecology
researchProduct

Inverse correlation between baseline inhibin B and FSH after stimulation with GnRH: a study of serum levels of inhibin A and B, pro alpha-C and activ…

2000

OBJECTIVE: Interest has focused recently on the influences of the polypeptide factors inhibin and activin on the selective regulation of the pituitary secretion of gonadotropins. DESIGN: Measurement of the concentrations of inhibin-related proteins in relation to the changes in pituitary gonadotropin (FSH, LH) parameters, after GnRH stimulation with a bolus injection of 100 microg gonadorelin, in 19 women with ovulatory disturbances. METHODS: Serum levels of inhibin A and B, activin A, and pro alpha-C were measured using sensitive ELISA kits. RESULTS: Within 60 min after GnRH stimulation, FSH values doubled from 5 to 10 mU/ml (P < 0.001). LH increased 12-fold from 2 to 24 mU/ml (P < 0…

Adultendocrine systemmedicine.medical_specialtyInhibin aAdolescentmedicine.drug_classEndocrinology Diabetes and MetabolismAlpha (ethology)StimulationGonadotropin-releasing hormoneGonadotropin-Releasing HormoneFollicle-stimulating hormoneEndocrinologyInternal medicinemedicineHumansInhibinsOvarian DiseasesAmenorrheaEstradiolChemistryHypogonadismGeneral MedicineLuteinizing HormoneActivinsEndocrinologyAmenorrheaFemaleGonadotropinmedicine.symptomFollicle Stimulating HormoneLuteinizing hormonehormones hormone substitutes and hormone antagonistsHypothalamic DiseasesEuropean journal of endocrinology
researchProduct

Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual func…

2017

Since features of polycystic ovary syndrome (PCOS) have been found to be prevalent in women with functional hypothalamic amenorrhea (FHA), we wished to determine what happens to these features after recovery of menstrual function in FHA Design: Prospective cohort study. Twenty-eight women with FHA and 30 age-matched ovulatory controls were studied.Twenty-eight women with FHA and 30 age-matched ovulatory controls were studied. We measured serum estradiol, LH, FSH, testosterone, DHEAS, anti-Mullerian hormone (AMH), body mass index, and ovarian morphology on transvaginal ultrasound.At baseline, 12 of the 28 women (43%) had increased AMH (4.7 ng/mL), and higher testosterone and larger ovaries c…

AdultAnti-Mullerian Hormoneendocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismHypothalamic amenorrheaYoung Adult03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicinemedicineHumansTestosteroneProspective StudiesAmenorrheaUltrasonography030219 obstetrics & reproductive medicineEstradiolDehydroepiandrosterone Sulfatebusiness.industryPolycystic ovary syndrome (PCOS)OvaryObstetrics and GynecologyTestosterone (patch)Luteinizing Hormonemedicine.diseasePolycystic ovaryhumanitiesMenstruationEndocrinologyOvarian morphologyFemaleFollicle Stimulating HormonebusinessHypothalamic DiseasesPolycystic Ovary SyndromeGynecological Endocrinology
researchProduct

Obesity status and obesity-associated gut dysbiosis effects on hypothalamic structural covariance

2021

[Background]: Functional connectivity alterations in the lateral and medial hypothalamic networks have been associated with the development and maintenance of obesity, but the possible impact on the structural properties of these networks remains largely unexplored. Also, obesity-related gut dysbiosis may delineate specific hypothalamic alterations within obese conditions. We aim to assess the effects of obesity, and obesity and gut-dysbiosis on the structural covariance differences in hypothalamic networks, executive functioning, and depressive symptoms.

AdultMalemedicine.medical_specialtyDisbiosisEndocrinology Diabetes and MetabolismHypothalamusMedicine (miscellaneous)StriatumIntestines -- MicrobiologyArticleBody Mass IndexGlàndules endocrinesInternal medicineNeural PathwaysmedicineHumansObesityEndocrine glandsNutrition and DieteticsHipotàlembusiness.industryFunctional connectivityMiddle Agedmedicine.diseaseObesityIntestins -- MicrobiologiaCross-Sectional StudiesEndocrinologyHypothalamusStructural covarianceObesitatDysbiosisFemaleGut dysbiosisbusinessInsulaHypothalamic DiseasesExecutive dysfunction
researchProduct